A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)

Annals of Oncology

Volumn 19, Issue 7, 2008, Pages 1304-1307

  Theodore, C ^a   Skoneczna, I ^b   Bodrogi, I ^c   Leahy, M ^d   Kerst, J M ^e   Collette, L ^f   Ven, K ^f   Marreaud S ^f   Oliver, R D T ^g  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^f EORTC DATA CENTER   (Belgium)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Advanced penile cancer; Chemotherapy; Cisplatin; Irinotecan

Indexed keywords

CISPLATIN; IRINOTECAN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; BLEEDING; CANCER RESEARCH; CANCER STAGING; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FATIGUE; FEBRILE NEUTROPENIA; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOTENSION; INTRACARDIAC THROMBOSIS; LIVER METASTASIS; LUNG DISEASE; LUNG METASTASIS; MALE; MALE GENITAL SYSTEM SURGERY; METASTASIS POTENTIAL; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PENIS CARCINOMA; PHASE 2 CLINICAL TRIAL; PLEURA METASTASIS; PRIORITY JOURNAL; SIDE EFFECT; SKIN METASTASIS; SOFT TISSUE METASTASIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 46249098611     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn149     Document Type: Article

References (25)

1. Smith Y, Hadway P, Biedrzycki O. et al. Reconstructive surgery for invasive squamous carcinoma of the glans penis. Eur Urol 2007; 52: 1179-1185.
2. Leijte JA, Kroon BK, Valdés Imos RA et al. Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol 2007;52:170-177.
3. Shammas FV, Ous S, Fössa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992; 147: 630-632.
4. Haas GP, Blumenstein BA, Gagliano R et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: A Southwest Oncology Group study. J Urol 1999; 161: 1823-1825.
5. Bermejo C, Busby JE, Spiess PE et al. Neoadjuvant chemotherapy-followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007; 177: 1335-1338.
6. Leijte JA, Kerst JM, Bais E et al. Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 2007; 52: 488-494.
7. Pizzocaro G, Piva L. Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol. 1988; 27(66): 823-824.
8. De Jonge MJ, Sparreboom A, Planting AS et al. Phase I study of the 3 week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors. J Clin Oncol 2000; 18: 187-194.
9. Boku N, Ohtsu A, Shimada Y et al. Phase II study of,a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol 1999; 17: 319-323.
10. Hermaneck P, Sobi H (eds): Union Internationale contre le Cancer: TNM Classification of Malignant Tumours, 5th edition. Berlin: Springer 1997; 130-132.
11. Therasse P et al. New guidelines to evaluate the respoose to treatment in solid tumors. J. Natl. Cancer Inst 2000; 92: 205-216.
12. CTC version 3: http://ctep.into.nih.gov/reporting/ctc_v30.html.
13. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989; 10: 1-10.
14. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: A challenge for the developing world. Lancet Oncol 2004; 5: 240-247.
15. Goodman MY, Hernandez BY, Schvtsov YB. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev 2007; 16: 1833-1839.
16. Schoen EJ. Neonatal circumcision and penile cancer. Evidence that circumcision is protective is overwhelming. BMJ 1996; 313(7048): 46.
17. Brown CT, Minhas S, Ralph DJ. Conservative surgery for penile cancer: subtotal glans excision without grafting. BJU Int 2005; 96: 911-912.
18. Tamari M, Tumar M, Shukla HS et al. YAG laser treatment of early stage carcinoma of the penis preserves form and function of penis. Asian J Surg 2007; 30: 126-130.
19. Crook JM, Grimard L, Tsihlias J et al. Penile brachytherapy: Results for 49 patients. Int J Radiat Oncol Biol Phys 2005; 62: 460-467.
20. Sklaroff-RB, Yagoda A. Methotrexate in the treatment of penile carcinoma. Cancer 1986, 45: 214-216.
21. Ahmed T, Sklaroff RB, Yagoda A. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 1984; 132: 465-468.
22. Hussein A, Benedetto P, Sridhar KS. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990; 65: 433-438.
23. Eisenberger MA, Chemotherapy for carcinomas of the penis and urethra, Urol Clin North Am 1992; 19: 333-338.
24. Dexeus FH, Logothetis CJ, Sella A et al. Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 1991; 146: 1284-1287.
25. Brinkman JA, Hughes SH, Stone P et al. Therapeutic vaccination for HPV induced cervical cancers, Dis Markers 2007; 23: 337-352.